A novel gelatin crosslinking method retards release of mulberry 1-deoxynojirimycin providing a prolonged hypoglycaemic effect
Mulberry 1-deoxynojirimycin (DNJ), a potent α-glycosidase inhibitor, has therapeutic potency in the suppression of postprandial blood glucose levels thereby possibly preventing diabetes mellitus. However, DNJ has a relatively short half-life in vivo (about 2 h). Therefore, several doses of mulberry...
Saved in:
Main Authors: | Vichasilp C., Nakagawa K., Sookwong P., Higuchi O., Kimura F., Miyazawa T. |
---|---|
Format: | Article |
Language: | English |
Published: |
2014
|
Online Access: | http://www.scopus.com/inward/record.url?eid=2-s2.0-84861573909&partnerID=40&md5=695d15649a4e75bb64b5d40c5304885d http://cmuir.cmu.ac.th/handle/6653943832/6701 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Language: | English |
Similar Items
-
A novel gelatin crosslinking method retards release of mulberry 1-deoxynojirimycin providing a prolonged hypoglycaemic effect
by: Chaluntorn Vichasilp, et al.
Published: (2018) -
Mulberry-Derived 1-Deoxynojirimycin Prevents Type 2 Diabetes Mellitus Progression via Modulation of Retinol-Binding Protein 4 and Haptoglobin
by: Fongsodsri K.
Published: (2023) -
Sulphate-based flame-retardant for handmade mulberry paper
by: Naksata W., et al.
Published: (2014) -
Sulphate-based flame-retardant for handmade mulberry paper
by: W. Naksata, et al.
Published: (2018) -
SYNTHESIS OF 1-DEOXYNOJIRIMYCIN-CONTAINING DISACCHARIDES
by: CHEN QIAN
Published: (2020)